CORONARY

VALVE & STRUCTURAL HEART

ENDOVASCULAR

SCIENCE

TECHNOLOGY

NURSE & TECH

Ron Waksman, MD Course Chairman

Dear Colleagues,

On behalf of all of the course co-directors, I am thrilled to present Cardiovascular Research Technologies (CRT) 2013. Building on many years of success, CRT 2013 is our most cutting-edge and comprehensive meeting to date. The course features concurrent meetings in six subject areas—Valve & Structural Heart, Coronary, Endovascular, Science, Technology and Nurse & Tech—all in CRT’s signature boutique setting. This robust program allows us to iMPACT YOUR PRACTICE with educational content that can be directly applied to your clinical and academic practice.

Among its many highlights, CRT 2013 features over 300 world-renowned faculty, live cases from seven sites across the globe, simulators and hands-on workshops. All of this is presented in an intimate atmosphere to allow frequent interaction with featured experts.

New to CRT 2013 is an investigation of the role of imaging of atherosclerotic plaque, a review of the status of HDL therapy and an introduction to renal denervation for the treatment of resistant hypertension. The four-day Valve & Structural Hearttrack continues to be the leading East Coast valve

meeting, and will feature an in-depth review of the diagnostic and therapeutic options for the treatment of valve and structural heart disease.

I look forward to welcoming you to Washington, DC and to CRT 2013.

Warm Regards,

Ron Waksman, MDCourse Chairman, CRT 2013

Valve Evening Symposium

On-Site Registration Opens

Evening Dinner Symposia

Valve & Structural Heart Revolution I

Exhibitor Reception

Breakfast Symposia

Women & Heart Disease Luncheon Symposium

CTO Forum

ACS & AMI Management

Cardiovascular Professionals’ Symposium for Nurses & Techs

Primer for Endovascular Interventions

Breakfast Symposia

Valve & Structural Heart Revolution IV

Complex Coronary Interventions II

Renal Denervation for Resistant Hypertension

Cardiovascular Innovations

FDA Town Hall

Peripheral Arterial Disease & Critical Limb Ischemia

Breakfast SymposiaAbstract Café

Evening Dinner Symposia

Valve & Structural Heart Revolution II & III

Complex Coronary Interventions I

The Essentials of Clinical Research

Atherosclerosis, Plaque Imaging and Lipid Therapy

DES Bioabsorbable and DCB Technologies

SATURDAY, FEBRUARY 23 SUNDAY, FEBRUARY 24 MONDAY, FEBRUARY 25 TUESDAY, FEBRUARY 26

FOR THE MOST UPDATED PROGRAM INFORMATION PLEASE VISIT CRTMEETING.ORG

COURSE DESCRIPTIONCardiovascular Research Technologies (CRT) 2013 will be the most comprehensive and cutting-edge CRT conference to date. Through six subject areas – Coronary, Valve & Structural Heart, Endovascular, Science, Technology and Nurse & Tech – CRT 2013’s 14 concurrent meetings are designed to impact practice with focused sessions that discuss new trial data, explore evidence-based research and demonstrate cutting-edge techniques that can be directly applied to the learners’ clinical and academic practice. This four-day conference will feature over 300 world-renowned faculty and live cases from seven sites across the globe.

The meetings as well as some of the breakfast and evening symposia in the Coronary, Endovascular, Science, Nurse & Tech and parts of the Valve & Structural Heart tracks are eligible for CME credit. The meetings in the Technology track as well as Valve & Structural Heart IV and the clinical simulation stations are not eligible for CME credit.

LEARNING OBJECTIVES• Compare the results from important

clinical trials and evidence-based medicine to guide management of patients with atherosclerosis and structural heart disease

• Incorporate new interventional technologies, drugs and procedures into the care of patients with complex coronary and endovascular disease

• Integrate advances in diagnostic evaluation and therapeutics to treat patients with carotid and peripheral arterial disease

• Assess percutaneous devices from device concept to preclinical trial to clinical investigation to regulatory approval and clinical application for the treatment of structural heart and valve disease

• Describe appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after cardiac catheterization

• Evaluate and develop an effective clinical research program

TARGET AUDIENCEThis educational program is designed for interventional cardiologists, clinical cardiologists, cardiac surgeons, fellows, emergency medicine specialists, primary care physicians, basic scientists, radiologists, interventional radiologists, nurses, technologists, industry professionals and other health care professionals who want to enhance their knowledge of complex coronary interventions and the treatment of patients with cardiovascular disease.

CME ACCREDITATION MedStar Washington Hospital Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATIONMedStar Washington Hospital Center designates this live activity for a maximum of 32 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS WITH ANY COMMERCIAL INTERESTAs a sponsor accredited by the ACCME, it is the policy of MedStar Washington Hospital Center to require that everyone who is in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest prior to the educational activity.

The ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. Faculty and planners who refuse to disclose relevant financial relationships will be disqualified from participating in the CME activity. For an individual with no relevant financial relationship(s), the participants must be informed that no conflicts of interest or financial relationship(s) exist.

SPECIAL ASSISTANCEMedStar Washington Hospital Center wishes to ensure that no individual with a disability is excluded, denied services, segregated or otherwise treated differently from other individuals because of the absence of auxiliary aids or services identified in the Americans with Disabilities Act. Please contact 202-877-8206 to notify us of your needs.

COURSE INFORMATION

CORONARYACS & AMI ManagementSunday, February 24

CTO ForumSunday, February 24

Complex Coronary InterventionsMonday, February 25 & Tuesday, February 26

COURSE DIRECTORSC. Michael Gibson, MD Neal S. Kleiman, MD

COURSE DIRECTORSRichard R. Heuser, MD Craig A. Thompson, MD

COURSE DIRECTORSMaurice Buchbinder, MDKenneth M. Kent, MD

Lowell F. Satler, MDRon Waksman, MD

HIGHLIGHTS

• New Antiplatelet Agents: How to Optimize Therapy for Patients with ACS and AMI

• How to Select the Appropriate Antiplatelet Agent

• Antiplatelet Therapy Responsiveness and Genomics

• Optimal Duration of DAPT

• How to Minimize Bleeding Complications

• Anticoagulation Protocols for NSTEMI/STEMI

• Strategies to Shorten Door-to-Balloon Time

• Hemodynamic Support Devices for Complex PCI and Cardiogenic Shock

• How to Manage the “No-Reflow” Phenomenon

• How to Shorten Door-to-Balloon Time

• OCT and FFR Use in STEMI Patients

HIGHLIGHTS

• Live Case Demonstrations from 7 International Sites

• Appropriate Use Criteria for PCI

• Clinical Trials that Will Impact Your Practice

• Unprotected Left Main: Patient Selection and Technique

• Thrombus and No-Reflow Management

• Bifurcation: Technical Strategies

• How to Manage Complications in PCI

• Transradial Access: Tips and Tricks

• When to Use FFR and when to Use IVUS

• How to Perform a Transseptal

• Use of Atheroablative Devices in 2013

• Management of Multivessel Disease

• Therapeutic Options for Saphenous Vein Grafts

HIGHLIGHTS

• CTO Recanalization: For Beginners through Masters

• New Wire and Support Catheter Technologies

• Antegrade and Retrograde Approach: Step-by-Step Tutorial

• CTO Complications

• Imaging to Guide CTO Recanalizations

• Live Case Demonstrations from the Experts in Japan

• Patient and Lesion Selection

• Strategies to Increase Your Success Rate

• New Devices and Tools for CTO Recanalization

• Challenging Case Reviews

• Strategies to Minimize Radiation and Contrast

• Radial Access for CTO

• Peripheral CTO

VALVE & STRUCTURAL HEART

FOR THE MOST UPDATED PROGRAM INFORMATION PLEASE VISIT CRTMEETING.ORG

HIGHLIGHTS

• Live Cases and Taped Case Sessions

• Review of the Latest Clinical Data from the Valve Studies

• Practical Tutorial: How to Start a Valve and Structural Heart Program

• Hands-On Simulators for Valve and Structural Heart Devices

• Review of the Latest Clinical Data on Valve & Structural Heart

• Tutorial on Interventional Techniques for Cardiothoracic Surgeons

• Review of Challenging Cases and Complications

• Parade of New Valve and Structural Heart Technology

• Regulatory and Health Care Issues Related to Valve and Structural Heart Disease

• Vascular Access and Closure

• Valve Revolution Evening Symposium

AORTIC VALVE

• How to Set Up a Successful TAVR Program in Your Institution: Readiness, Planning and Training

• TAVR Technology: Balloon-Expandable and Self-Expandable Technology Update

• TAVR: Step-by-Step Guidance

• TAVR Technology: Balloon-Expandable and Self-Expandable Technology Update

• TAVR: Review of the Latest Clinical Data

• Transapical vs. Transfemoral

• Transaortic and Subclavian Access for TAVR

• Imaging for TAVR

• Transcatheter Valve-in-Valve

• How to Minimize Aortic Regurgitation

• TAVR for Lower Risk Patients

• Embolic Protection Devices to Minimize Stroke

MITRAL VALVE

• Understanding Mitral Valve Disease

• Percutaneous Mitral Valve Repair Technology: Update, Techniques, Patient Selection and Therapeutic Options

• Understanding Treatment Options for Mitral Regurgitation

• Percutaneous Mitral Valve Replacement

STRUCTURAL HEART

• Left Atrial Appendage Closure: Technology Update and Review of the Data

• PFO Closure in 2013: Indications and Device Selection

• VSD Closure

• Valvular Leak Closure: Technology and Technique

Valve & Structural Heart RevolutionSaturday, February 23 – Tuesday, February 26

COURSE DIRECTORSNiv Ad, MDPaul J. Corso, MDEberhard Grube, MD

Michael J. Mack, MD Augusto D. Pichard, MD Ron Waksman, MD

ENDOVASCULARPrimer for Endovascular InterventionsSunday, February 24

Peripheral Arterial Disease & Critical Limb IschemiaMonday, February 25

COURSE DIRECTORSJ. Michael Bacharach, MD, MPH Nelson L. Bernardo, MDMark H. Wholey, MD

COURSE DIRECTORSJ. Michael Bacharach, MD, MPH Nelson L. Bernardo, MDMark H. Wholey, MD

HIGHLIGHTS

• Techniques and Imaging Guidance for Femoral Artery Access

• Approaches to Access of the Radial, Brachial and Popliteal Arteries

• Hemostasis with Suture-Mediated Vascular Closure Devices and Vascular Closure Plugs

• Endovascular Approach to Aorto-Iliac Occlusive Disease

• Retrograde Pedal Artery Access Techniques

• Intervention of the Subclavian, Renal and Mesenteric Arteries

• Tutorial on the Use of Various Atherectomy Devices

• Surgical and Endovascular Approach to Acute Limb Ischemia

• Carotid Artery Revascularization with Surgery or Stenting

• Catheter-Based Treatment of DVT

• Choosing and Implanting an IVC Filter

• Treating Pulmonary Embolism in the Cath Lab

• EVAR Planning and Step-by-Step Device Implantation

• Dealing with Complications of the Various Arterial Beds

HIGHLIGHTS

• Live Case Demonstrations

• LINC at CRT

• Interesting and Complicated Case Review

• Complications and Bailout Sessions

• Chronic Limb Ischemia: New Tools and Techniques

• New Atherectomy Devices for SFA and Below-the-Knee

• Laser Angioplasty for Limb Salvage

• OCT-Guided Atherectomy for SFA Reacanalization

• CTO for SFA and Below-the-Knee

• Drug-Coated Balloon and Drug-Eluting Stent Technologies for Endovascular Therapy of PAD

• Management of Chronic Limb Ischemia and Infrapopliteal Disease

• Strategies to Minimize Amputations

• Hands-On Simulation Stations

ENDOVASCULAR

FOR THE MOST UPDATED PROGRAM INFORMATION PLEASE VISIT CRTMEETING.ORG

TECHNOLOGYDES Bioabsorbable and DCB TechnologiesMonday, February 25

Renal Denervation for Resistant HypertensionTuesday, February 26

Cardiovascular InnovationsTuesday, February 26

FDA Town HallTuesday, February 26

COURSE DIRECTORSAlexandre Abizaid, MD, PhD Adnan Kastrati, MD Laura Mauri, MD

COURSE DIRECTORSHorst Sievert, MD Ron Waksman, MD

COURSE DIRECTORSSteven R. Bailey, MD Ran Kornowski, MD

COURSE DIRECTORSAndrew Farb, MD John S. Sapirstein, MD Ron Waksman, MDBram D. Zuckerman, MD

HIGHLIGHTS

• Third Generation DES: Update on Technology and Clinical Outcomes

• Review of the Latest Data on DES with Durable Polymers

• New DES Technology with Biodegradable Polymers

• DES with Polymer-Free Technology

• The Biodegradable Stent Symposium

• The Drug-Coated Balloon Symposium

• Strategies to Minimize Stent Thrombosis

• Industry Update on Technology

HIGHLIGHTS

• Pathophysiology and Mechanism for Sympathetic Renal Denervation

• Patient Selection and Eligibility

• How to Perform the Procedure: Case Presentations

• RF Technology

• Ultrasound Technology

• Local Drug Delivery

• Brachytherapy

• Clinical Trial Updates

• Potential Future Indications: Diabetes, Heart Failure, Sleep Apnea, Renal Artery Stenosis

HIGHLIGHTS

• Cardiovascular Innovations Competition

• Robotic Angioplasty in the Cath Lab

• Telemedicine Devices to Detect Coronary Events

• Embolic Protection Devices

• Artificial Heart

• New Percutaneous Valves and Valve Repair Devices

• VSD, ASD, PFO & LAA Closures

• Percutaneous Therapies for the Treatment of Erectile Dysfunction

• ICI @ CRT: A Parade of Novel Technologies from Israel

HIGHLIGHTS

• Valve and Regulatory Issues

• Pathways for Approval of Bioabsorbable Technologies

• Drug-Coated Balloons

• TAVR Trial Design for Intermediate Risk Patient with AS

• Renal Denervation Regulatory Aspects

• Trial Design for Mitral Valve Repair

• Reviving First-in-Man Studies in the US

• How Will Health Care Reform Impact Innovation in Cardiovascular Medicine?

• Update on 510(k)

• Pathways to Shorten PMA Approval Time

SCIENCE NURSE & TECHAtherosclerosis, Plaque Imaging and Lipid TherapyMonday, February 25

The Essentials of Clinical ResearchMonday, February 25

Cardiovascular Professionals’ Symposium for Nurses & TechsSunday, February 24

COURSE DIRECTORSH. Bryan Brewer, Jr., MD Renu Virmani, MD Robert L. Wilensky, MD

COURSE DIRECTORSAjay J. Kirtane, MD Alexandra J. Lansky, MD

COURSE DIRECTORSRegina Deible, RN, BSN Marsha Holton, CCRN, RCIS Julie Logan, RN Steven Simms, BSN, RN

HIGHLIGHTS

• New Mechanisms

• Non-Invasive Plaque Imaging

• OCT

• IVUS/VH

• LIPISCAN

• CT/FFR

• IVUS/FFR Correlation

• Lipid Content and Vulnerable Plaque

• CETP Inhibitors: Update on Clinical Trials

• New Insights into HDL Therapy, Dysfunctional HDL and Cardiovascular Genetics

• Review of Clinical Trials

• Emerging Directions for Diagnosis and Treatment of Dyslipidemia

HIGHLIGHTS

• How to Develop a Successful Research Program

• Clinical Research: The Basic Roadmap and Essentials of Study Design

• Investigator-Sponsored Trials

• How to Survive an FDA Audit

• How to Write a Successful Grant

• How to Improve Enrollment in Clinical Trials

• Interventional Cardiovascular Research: Experimental Pathways and Regulatory Requirements for Device Approval

• Basic Statistics for the Trialist

HIGHLIGHTS

• Successful Sedation: Know Your Options

• Closure Devices for Nurse and Tech Management

• Access Management: Radial vs. Femoral

• To Stent or Not to Stent: Health Care Appropriate Decisions

• A Balanced Approach to PCI: Treating Ischemia and Eliminating Bleeding

• Renal Denervation: Hope or Hype?

• Cath Lab Credentials: Who Runs the Table in 2013?

• Cath Lab Cross Coverage

• Women & Heart Disease Luncheon Symposium

• Impact of Health Care Reform on Cath Lab Efficiency

• Prepare Your Lab for a Percutaneous Valve Program

• Conquering the Complex PCI & STEMI

• Hot Trends in the Lab

FOR THE MOST UPDATED PROGRAM INFORMATION PLEASE VISIT CRTMEETING.ORG

CALL FOR ABSTRACTSThe CRT 2013 Abstract Committee invites you to submit abstracts of original investigations for consideration at CRT 2013. Abstracts should constitute original research, (clinical studies, basic investigation and animal studies are equally encouraged) in the field of cardiovascular medicine and intervention. The top abstracts will be presented orally at CRT 2013 and the presenting authors will be listed as CRT 2013 Associate Faculty.

CALL FOR INTERESTING CASESCRT 2013 invites you to showcase interesting and challenging cases for educational purposes. We are particularly interested in cases in the following categories:•Coronary Intervention•Endovascular Intervention •Valve & Structural Heart Disease •Renal Denervation •Complications

CALL FOR CARDIOVASCULAR INNOVATIONSDo you have a great idea for a new innovative product? We are actively searching for the latest cardiovascular innovations, inventions and therapies to be presented and discussed at CRT 2013. Please submit information on devices, software, imaging equipment, percutaneous valve therapies, stent technologies, structural heart devices, endovascular intervention technologies. Submit your innovations to be considered for the Best Innovation Award.

All Cardiovascular Innovations submissions will be reviewed and graded by the CRT Faculty Review Panel; selected submissions will be presented at the Cardiovascular Innovations session on Tuesday, February 26, 2013.

CALL FOR iMPACT TRIALSSubmit your iMPACT Trials for presentation at CRT 2013. iMPACT Trials are innovative reports which provide the latest breakthroughs in clinical science. The studies selected are expected to highlight new improvements for quality of patient care and significantly “iMPACT” the field of interventional cardiology. In addition to the exposure among colleagues and in the press, selected iMPACT Trial presenters will become CRT 2013 Associate Faculty.

CALL FOR YOUNG LEADERSThe Young Leadership Recognition Program is designed to feature current and future clinical and academic excellence in physicians practicing interventional cardiology and endovascular medicine. A special symposium including current leaders in the field from academia, industry and the FDA will be held at CRT 2013 for the selected Young Leadership Recognition Program participants.

CALL FOR SUBMISSION DEADLINE

Abstracts November 16, 2012

Cardiovascular Innovations November 16, 2012

Interesting Cases November 16, 2012

Young Leaders November 16, 2012

iMPACT Trials December 20, 2012

HOW TO BECOME CRT 2013 ASSOCIATE FACULTY CRT 2013 is pleased to invite you to become an Associate Faculty member. You may be eligible for the title of Associate Faculty in one of the following ways:

• Your abstract is selected to be presented orally.• Your Interesting Case submission is selected to be presented during an Interesting Case Session at CRT 2013.• Your iMPACT Trial is selected to be presented at CRT 2013.

CALL FOR SUBMISSIONS

Accepted CRT 2013 abstracts meeting the eligibility requirements will be published in the Journal of the American College of Cardiology (JACC) Interventions.

LIVE CASE DEMONSTRATION SITES

Brussels University HospitalBrussels, Belgium

Kusatsu Heart CenterKusatsu, Japan

MedStar Washington Hospital Center Washington, DC

Morristown Medical CenterMorristown, New Jersey

Mount Sinai Medical Center New York, New York

Park Hospital Leipzig, Germany

San Raffaele Hospital Milan, Italy

EXHIBITOR RECEPTIONPlease join us Sunday, February 24, 2013, from 5:30 – 7:00 PM for an assortment of hors d’oeuvres, festive food stations, drinks and music while interacting with exhibitors.

EXHIBIT HALL HOURSSunday, February 24 11 AM – 7 PMMonday, February 25 8 AM – 5 PMTuesday, February 26 9 AM – 2 PM

EXHIBITSIs your company interested in exhibiting at CRT 2013? Please visit CRTmeeting.org and click “Exhibitors” to view the Exhibitor Prospectus for exhibiting and sponsorship information. Please complete the online registration form to reserve your space today!

ABSTRACT CAFÉCRT 2013 will be hosting the Abstract Café featuring accepted abstracts on Monday, February 25. This event is a wonderful networking opportunity for abstract authors, attendees and exhibitors. The Abstract Café will be the sole activity of the meeting from 8:00 – 9:00 AM in the CRT 2013 Exhibit Hall. Complimentary food and beverages will be served.

Join us for the 4th Annual Women & Heart Disease Symposium at CRT 2013. This special lunch session discusses the disparities in detecting and treating heart disease in women. With its outstanding faculty and candid panel discussions, this session has become a “must-attend” program at CRT.

DISPARITIES IN INTERVENTIONAL CARDIOLOGYDisease and Lesion Specific Monday, February 25, 2013

Developed in collaboration with the Association of Black Cardiologists (ABC), this special luncheon event will examine the range of disparities in treating patients, including gender, racial and economic, and will discuss ways to address them.

prevention, detection & treatment

Luncheon SymposiumSunday, February 24, 2013 12 – 2 PM

LIVE CASES & SPECIAL EVENTS

AN EVENING WITH RUDY GIULIANIMONDAY, FEBRUARY 25, 2013 | 8:00 PMRudolph W. Giuliani, 107th Mayor of New York City (1993 – 2007), has been touted as one of the most effective chief executives in modern American history. A leader to whom America and much of the world turned to in a time of crisis, Giuliani was named TIME magazine’s 2001 Person of the Year, given an honorary knighthood by the Queen of England and awarded the Ronald Reagan Presidential Freedom Award. Never one to shy away from a battle, Giuliani almost single-handedly took on organized and white-collar crime in New York. Since leaving office, Rudy Giuliani established Giuliani Partners, a professional services firm focusing on strategic consulting, emergency preparedness and leadership.  He is also a partner in the law firm Bracewell & Giuliani.

THE OMNI SHOREHAM HOTEL2500 Calvert Street NW Washington, DC 20008 Phone: (202) 234-0700

RESERVE YOUR ROOMA block of rooms has been reserved at the discounted rate of $259 per room, per night, single or double occupancy for CRT 2013 attendees. The tax is 14.5% per room, per night.

There are two ways to reserve your room:

BY PHONE: Please call Central Reservations at: 1-800-THE-OMNI (800-843-6664). Please indicate that you will be attending “CRT 2013” to receive the preferred group rate.

ONLINE: Visit www.CRTmeeting.org and click on the ‘Hotel Information’ link listed on the left side for a direct link to make online hotel reservations.

The cut-off date for making reservations is Friday, January 25, 2013. Reservation requests received after that date will be based on availability at the hotel’s prevailing rates.

FOR THE MOST UPDATED PROGRAM INFORMATION PLEASE VISIT CRTMEETING.ORG

REGISTRATION Please register early. Advance registrations will not be accepted after February 20, 2013. After this date, registration will only be available on-site for an additional fee of $100. Registrations will not be accepted by telephone. For more information, call (202) 877-8206 or email CRTmeeting@gmail.com.

uProof of government regulatory agency status is required for special discount (US FDA or NIH only). *Specified full meeting registrants will receive a complimentary one-year subscription to CRM Journal.

EARLY REGISTRATION DISCOUNT FOR PHYSICIANS The earlier you register, the lower the registration fee.

CANCELLATION POLICYCancellations made in writing before November 1, 2012 will be refunded in full. Cancellations made in writing between November 1, 2012 and December 31, 2012 will be subject to a $150 cancellation fee. No refunds will be given after December 31, 2012. Cancellations will not be accepted by telephone. In the unlikely event that the course is canceled, MedStar Washington Hospital Center will refund the registration fee, but is not responsible for any travel costs.

REGISTRATION DATE Now – October 31, 2012 November 1, 2012 – February 20, 2013

FEE $840 $990

REGISTRATION TYPE PHYSICIAN ALLIED HEALTH PROFESSIONAL FELLOW

SCIENTIST /RESEARCH

PROFESSIONAL

INDUSTRY PROFESSIONAL

REGULATORY AGENCY EMPLOYEEu

FULL MEETING $840 - $990*

$590* $590 $590 $1190 $350

SUNDAY ONLY $575 $195

MONDAY ONLY $295

REGISTRATION & HOTEL INFORMATION

CRT 2013110 Irving Street, NW, Suite 6D21Washington, DC 20010

CALL FOR SUBMISSION DEADLINE

Abstracts November 16, 2012

Cardiovascular Innovations November 16, 2012

Interesting Cases November 16, 2012

Young Leaders November 16, 2012

iMPACT Trials December 20, 2012

NON-PROFIT ORG.U.S. POSTAGE

PAIDWASHINGTON

HOSPITALCENTER

IMPORTANT DEADLINES

HIGHLIGHTS FOR CRT 2013› 300 Renowned Faculty› 7 Live Case Sites from Around the World› Simulators and Hands-On Workshops› Expanded Valve and Structural Heart Revolution Program› Updated Atherosclerosis, Plaque Imaging and Lipid Therapy Course› Bioabsorbable Scaffold and DCB Technologies Symposia › New Renal Denervation for Resistant Hypertension Course› iMPACT Trials› Abstracts to be published in JACC Interventions› FDA Town Hall Meeting

Questions? Please call 202-877-8206 or email CRTMeeting@gmail.com